Here is the link to the AMA, May 6 2019 on Reddit:

We’re WinSanTor, a patient owned pharmaceutical company with a drug that aims to reverse peripheral neuropathy AMA! : IAmA

Lots of reasons to be cautiously optimistic, IMHO. I quote from Stanley Kim, CEO:

When you say "reversal" do you mean alleviating symptoms or actually reversing damage and healing nerves? Can it also stop progression of further damage?

Stan: The studies in humans included biopsies as well as funtional tests. It showed signficant improvement of both. Again, this was by our scientists to understand whether our class of drugs would work. One of those drugs worked very well (tested on humans). We are taking what we believe to be the safest of those drugs (from the class of drugs tested on animals) forward.

I'll put in another pitch here for folks to fill in the patient survey on their web page:

Home - WinSanTor

There is so little research being done on PN by big pharma that I think it behooves us all to support the company in its efforts to find a treatment and to keep neuropathy in the news. The fact is, after some big trial fails, and with a focus on more profile health issues, big pharma is not at all interested in backing PN research; this is a company set-up by specialists on the back of government grants. Let's show them our support! At the very least, they offer a glimmer of hope.

Paul